These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25443697)

  • 1. The heterogeneity of heart failure: will enhanced phenotyping be necessary for future clinical trial success?
    Francis GS; Cogswell R; Thenappan T
    J Am Coll Cardiol; 2014 Oct; 64(17):1775-6. PubMed ID: 25443697
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications of chronic heart failure phenotypes defined by cluster analysis.
    Ahmad T; Pencina MJ; Schulte PJ; O'Brien E; Whellan DJ; Piña IL; Kitzman DW; Lee KL; O'Connor CM; Felker GM
    J Am Coll Cardiol; 2014 Oct; 64(17):1765-74. PubMed ID: 25443696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply: applying cluster analysis to data of previously published chronic heart failure trials: systems biology and clinical phenotypes of heart failure syndrome.
    Ahmad T; Felker GM
    J Am Coll Cardiol; 2015 Mar; 65(12):1270-1271. PubMed ID: 25814240
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: applying cluster analysis to data of previously published chronic heart failure trials.
    Francis GS; Cogswell R; Thenappan T
    J Am Coll Cardiol; 2015 Mar; 65(12):1270. PubMed ID: 25814241
    [No Abstract]   [Full Text] [Related]  

  • 5. Systems biology and clinical phenotypes of heart failure syndrome.
    Louridas GE; Lourida KG
    J Am Coll Cardiol; 2015 Mar; 65(12):1269-1270. PubMed ID: 25814239
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of proBNP1-108 testing for the risk stratification of patients with systolic heart failure.
    Gruson D; Lepoutre T; Ahn SA; Rousseau MF
    Peptides; 2013 Dec; 50():125-8. PubMed ID: 24140405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise tests in heart failure patients: is simple better?
    Rubin SA
    J Am Coll Cardiol; 2012 Dec; 60(25):2662-3. PubMed ID: 23177291
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive value of 6-min walk test distance versus cardiopulmonary exercise testing in systolic heart failure: same value for different approaches?
    Guazzi M; Bandera F
    J Am Coll Cardiol; 2013 May; 61(20):2112. PubMed ID: 23524047
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary flow reserve as a link between diastolic and systolic function and exercise capacity in heart failure.
    Snoer M; Monk-Hansen T; Olsen RH; Pedersen LR; Nielsen OW; Rasmusen H; Dela F; Prescott E
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):677-83. PubMed ID: 23169759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of improvement in six-minute walk distance from admission to discharge in acute systolic heart failure: Analysis from the ESCAPE trial.
    Omar HR; Guglin M
    Cardiol J; 2017; 24(2):227-230. PubMed ID: 28421593
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: To PMID 23177293.
    Forman DE; Fleg JL; Kitzman DW; Bittner V
    J Am Coll Cardiol; 2013 May; 61(20):2113. PubMed ID: 23524052
    [No Abstract]   [Full Text] [Related]  

  • 13. Autonomic nervous system in heart failure: an endless area of research/ The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
    Kardeşoğlu E; Işılak Z; Yalçın M; Celik T
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):373; author reply 373-4. PubMed ID: 21592933
    [No Abstract]   [Full Text] [Related]  

  • 14. Reverse remodelling in systolic heart failure: A puzzle yet to be solved?
    Yalta K
    Int J Cardiol; 2015 May; 187():46-7. PubMed ID: 25828311
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum.
    De Keulenaer GW; Brutsaert DL
    Circulation; 2011 May; 123(18):1996-2004; discussion 2005. PubMed ID: 21555722
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical practice. Systolic heart failure.
    McMurray JJ
    N Engl J Med; 2010 Jan; 362(3):228-38. PubMed ID: 20089973
    [No Abstract]   [Full Text] [Related]  

  • 18. Melanoma cell adhesion molecule as an emerging biomarker with prognostic significance in systolic heart failure.
    Banach J; Grochowska M; Gackowska L; Buszko K; Bujak R; Gilewski W; Kubiszewska I; Wołowiec Ł; Michałkiewicz J; Sinkiewicz W
    Biomark Med; 2016 Jul; 10(7):733-42. PubMed ID: 27355366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced expiratory volume in one second: prognostic value in systolic heart failure.
    Miniati M; Monti S; Bottai M; Passino C; Emdin M; Poletti R
    Int J Cardiol; 2013 Sep; 168(2):1573-4. PubMed ID: 23465247
    [No Abstract]   [Full Text] [Related]  

  • 20. The other side of heart failure.
    Johns Hopkins Med Lett Health After 50; 2009 Aug; 21(6):4-5. PubMed ID: 19722311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.